Immune biomarkers of increased infection risk in multiple myeloma.
Zabaleta A, Tamariz-Amador LE, Kostopoulos IV, Sklavenitis-Pistofidis R, Smits F, Rodriguez-Otero P, Roncal C, Aranha MP, Zihala D, Machu M, Tsakirakis N, Bakouros P, Tsitsilonis O, Solia I, Moreno C, Maia C, Martin-Sanchez E, Perez JJ, Encinas C, Rios-Tamayo R, Oriol A, Blanchard MJ, de Arriba F, Gonzalez ME, Lakhwani S, Sureda A, Cabañas V, Escalante F, Carrillo-Cruz E, Pérez-Montaña A, Ocio EM, Bargay J, Orfao A, Jelinek T, Ghobrial IM, Mutis T, Zweegman S, Terpos E, Kastritis E, Martinez-Lopez J, Lahuerta JJ, Fernandez de Larrea C, Rosiñol L, Bladé J, Mateos MV, San-Miguel J, Cedena MT, Puig N, Paiva B.
Zabaleta A, et al. Among authors: kostopoulos iv.
Blood. 2026 Apr 30;147(18):2081-2088. doi: 10.1182/blood.2025031744.
Blood. 2026.
PMID: 41610428